Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Susan Yonemura"'
Publikováno v:
PLoS ONE, Vol 12, Iss 6, p e0178725 (2017)
In resource-limited settings and in the military theater, fresh human whole blood is commonly transfused, but infectious risks are a concern. Sophisticated molecular testing for potential infectious agents in the whole blood is often unavailable. To
Externí odkaz:
https://doaj.org/article/97b6741154a34692a74455d0c4c7e0d7
Autor:
Marcela Henao-Tamayo, Lindsay Hartson, Susanne Marschner, Taru S. Dutt, Susan Yonemura, Raymond P. Goodrich
Publikováno v:
Vox Sanguinis
Background and ObjectiveConvalescent plasma (CP) has been embraced as a safe therapeutic option for coronavirus disease 2019 (COVID-19) while other treatments are developed. However, transfusion-transmitted disease is a risk, particularly in regions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d8b5e583394e56676a34665d64e1404
https://doi.org/10.1101/2021.02.18.21251437
https://doi.org/10.1101/2021.02.18.21251437
Autor:
Izabela K Ragan, Lindsay Hartson, Richard A. Bowen, Nicole K. Dart, Shawn D. Keil, Susan Yonemura
Publikováno v:
Vox Sanguinis
Background and objective Severe acute respiratory distress syndrome coronavirus-2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is a member of the coronavirus family. Coronavirus infections in humans are typically associat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::729ae06a1f7d7ec9069b5977e38bbe4f
Autor:
E Jane Gosney, Melissa Tran, Raymond P. Goodrich, Susan Yonemura, Heather L. Reddy, Suzann K. Doane, Nick Hovenga, Susanne Marschner, Lina Y Dimberg, Shilo Wilkinson
Publikováno v:
Transfusion Medicine and Hemotherapy. 46:240-247
Background: The Mirasol system for whole blood (WB) is a non-toxic, non-mutagenic pathogen reduction technology (PRT) that treats WB units with riboflavin (vitamin B2) and ultraviolet (UV) light to alter nucleic acids, thereby reducing pathogen infec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3922bf55540cabd08d836a9b60e0804f
https://doi.org/10.1159/000495257
https://doi.org/10.1159/000495257
Publikováno v:
PloS one, vol 12, iss 6
PLoS ONE
PLoS ONE, Vol 12, Iss 6, p e0178725 (2017)
PLoS ONE
PLoS ONE, Vol 12, Iss 6, p e0178725 (2017)
In resource-limited settings and in the military theater, fresh human whole blood is commonly transfused, but infectious risks are a concern. Sophisticated molecular testing for potential infectious agents in the whole blood is often unavailable. To
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f18bb0774fe020768e91400088ba0b78
https://escholarship.org/uc/item/3277p2j1
https://escholarship.org/uc/item/3277p2j1
Autor:
Anne Catrine Simonsen, Pär I. Johansson, Pascale Van Hoydonck, Susan Yonemura, Sisse R. Ostrowski, Peter de Nully Brown, Liesbeth Deberdt, Raymond P. Goodrich
Publikováno v:
Transfusion. 53:2043-2052
Background Platelet (PLT) support is critical to the care of patients with thrombocytopenia, but allogeneic transfusions carry risk. Pathogen reduction mitigates some transfusion risks, but effects on PLT function remain a concern. This clinical pilo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb0ce0d993b1350c3578fa88af0745c0
https://doi.org/10.1111/trf.12055
https://doi.org/10.1111/trf.12055